1,3-Disubstituted Ureas Functionalized with Ether Groups are Potent Inhibitors of the Soluble Epoxide Hydrolase with Improved Pharmacokinetic Properties
- 26 September 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 50 (21), 5217-5226
- https://doi.org/10.1021/jm070705c
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Design of bioavailable derivatives of 12-(3-adamantan-1-yl-ureido)dodecanoic acid, a potent inhibitor of the soluble epoxide hydrolaseBioorganic & Medicinal Chemistry, 2007
- Solid-phase combinatorial approach for the optimization of soluble epoxide hydrolase inhibitorsBioorganic & Medicinal Chemistry Letters, 2006
- Synthesis and SAR of conformationally restricted inhibitors of soluble epoxide hydrolaseBioorganic & Medicinal Chemistry Letters, 2006
- High-throughput pharmacokinetic method: Cassette dosing in mice associated with minuscule serial bleedings and LC/MS/MS analysisAnalytica Chimica Acta, 2006
- An Orally Active Epoxide Hydrolase Inhibitor Lowers Blood Pressure and Provides Renal Protection in Salt-Sensitive HypertensionHypertension, 2005
- Optimization of Amide-Based Inhibitors of Soluble Epoxide Hydrolase with Improved Water SolubilityJournal of Medicinal Chemistry, 2005
- Soluble Epoxide Hydrolase Is a Main Effector of Angiotensin II–Induced HypertensionHypertension, 2005
- IN VITRO METABOLISM OF THE MAMMALIAN SOLUBLE EPOXIDE HYDROLASE INHIBITOR, 1-CYCLOHEXYL-3-DODECYL-UREADrug Metabolism and Disposition, 2003
- Activation of Gαs Mediates Induction of Tissue-type Plasminogen Activator Gene Transcription by Epoxyeicosatrienoic AcidsPublished by Elsevier BV ,2001
- A new class of lipid mediators: cytochrome P450 arachidonate metabolitesThorax, 2000